Ontario drug reform savings in jeopardy: CPGA
Changes to Canada’s drug patent system proposed by the European Union would wipe out savings from the Ontario government’s drug reforms, according to Jim Keon, president of the Canadian Generic Pharmaceutical Association (CGPA).